These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17786288)

  • 41. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
    Liu S; Ren S; Howell P; Fodstad O; Riker AI
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions.
    García P; Manterola C; Araya JC; Villaseca M; Guzmán P; Sanhueza A; Thomas M; Alvarez H; Roa JC
    Mol Carcinog; 2009 Jan; 48(1):79-89. PubMed ID: 18543280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer.
    Marsit CJ; Houseman EA; Schned AR; Karagas MR; Kelsey KT
    Carcinogenesis; 2007 Aug; 28(8):1745-51. PubMed ID: 17522068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of myopodin methylation in bladder cancer.
    Cebrian V; Alvarez M; Aleman A; Palou J; Bellmunt J; Gonzalez-Peramato P; Cordón-Cardo C; García J; Piulats JM; Sánchez-Carbayo M
    J Pathol; 2008 Sep; 216(1):111-9. PubMed ID: 18636402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of novel epigenetic markers for clear cell renal cell carcinoma.
    Dalgin GS; Drever M; Williams T; King T; DeLisi C; Liou LS
    J Urol; 2008 Sep; 180(3):1126-30. PubMed ID: 18639284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma.
    Ksiaa F; Ziadi S; Amara K; Korbi S; Trimeche M
    Clin Chim Acta; 2009 Jun; 404(2):128-33. PubMed ID: 19336228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
    Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA hypomethylation of CAGE promotors in squamous cell carcinoma of uterine cervix.
    Lee TS; Kim JW; Kang GH; Park NH; Song YS; Kang SB; Lee HP
    Ann N Y Acad Sci; 2006 Dec; 1091():218-24. PubMed ID: 17341616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Primary signet ring adenocarcinoma ofa diverted neurogenic bladder].
    Weiss AM; Jeandel R; Lugagne-Delpon PM; Kamalodine T; Barbanel C
    Ann Pathol; 1995; 15(2):131-3. PubMed ID: 7755802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Classic bladder exstrophy and adenocarcinoma of the bladder: Methylome analysis provide no evidence for underlying disease-mechanisms of this association.
    Sharma A; Fröhlich H; Zhang R; Ebert AK; Rösch W; Reis H; Kristiansen G; Ellinger J; Reutter H
    Cancer Genet; 2019 Jun; 235-236():18-20. PubMed ID: 31296310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary signet ring cell adenocarcinoma of the bladder with elevated serum carbohydrate antigens 19-9 and 50.
    Ohnita T; Sakai H; Matsuo M; Hisamatsu H; Shimokawa I; Saito Y
    J Urol; 1998 May; 159(5):1641. PubMed ID: 9554373
    [No Abstract]   [Full Text] [Related]  

  • 54. CHFR gene is neither mutated nor hypermethylated in ovarian cancer.
    Ludwig AH; Bujko M; Bidzinski M; Kupryjańczyk J
    Cancer Detect Prev; 2007; 31(3):257-61. PubMed ID: 17673375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Signet ring cells in gastric carcinomas are derived from neuroendocrine cells.
    Bakkelund K; Fossmark R; Nordrum I; Waldum H
    J Histochem Cytochem; 2006 Jun; 54(6):615-21. PubMed ID: 16344325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Promoter hypermethylation as a biomarker in prostate adenocarcinoma.
    Park JY
    Methods Mol Biol; 2015; 1238():607-25. PubMed ID: 25421683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Primary signet ring cell carcinoma of urinary bladder. A case report].
    Krichen Makni S; Ellouz S; Khabir A; Daoud J; Boudawara T
    Cancer Radiother; 2005 Sep; 9(5):332-4. PubMed ID: 15949964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Signet ring cell differentiation of transitional cell carcinomas of the bladder.
    Moll C; Landolt U; Pedio G
    Acta Cytol; 1996; 40(3):619-21. PubMed ID: 8669213
    [No Abstract]   [Full Text] [Related]  

  • 59. Gene promoter methylation--a potential cancer marker.
    Ze-Jun- L; Masato M
    Adv Clin Path; 2002 Jan; 6(1):43-6. PubMed ID: 17582948
    [No Abstract]   [Full Text] [Related]  

  • 60. [Molecular biology advances and perspectives in urology].
    Feria Bernal G; Arroyo Kuribreña JC
    Rev Invest Clin; 2003; 55(2):243-7. PubMed ID: 12827935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.